Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Mantecorp Industria Quimica e Farmaceutica S.A.
Legal Form: Public Limited Company
Operational Status: Closed
Incorporation Date: 08-Aug-66
Mantecorp was formed in 2006 as an independent organization, after 17 years of partnership with North American Schering-Plough. The company has six product lines - Respiratory, Dermatology, Central Nervous System, Pediatric, Orthopedics, Gynecological and Obstetric. It also works in the Biotechnological segment, which deals with drugs for the treatment of diseases of high complexity, and the Medicines Exempted from prescription.More
|Company Tear Sheet|
|NAICS Industry Classification||✓|
|Share Price information||✕|
|Subsidiaries and Affiliates||✕|
|Key Financial Highlights||✕|
|Financial Performance Charts||✕|
|Latest M&A and ECM Deals||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.